Jaguar Health/$JAGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jaguar Health
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Ticker
$JAGX
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
49
Website
Jaguar Health Metrics
BasicAdvanced
$3.2M
-
-$93.54
0.70
-
Price and volume
Market cap
$3.2M
Beta
0.7
52-week high
$15.48
52-week low
$2.27
Average daily volume
98K
Financial strength
Current ratio
1.079
Quick ratio
0.251
Long term debt to equity
586.033
Total debt to equity
1,156.44
Profitability
EBITDA (TTM)
-30.159
Gross margin (TTM)
82.34%
Net profit margin (TTM)
-343.92%
Operating margin (TTM)
-277.33%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-37.48%
Return on equity (TTM)
-459.52%
Valuation
Price to revenue (TTM)
0.088
Price to book
0.9
Price to tangible book (TTM)
-0.1
Price to free cash flow (TTM)
-0.034
Free cash flow yield (TTM)
-2,956.83%
Free cash flow per share (TTM)
-7,036.15%
Growth
Revenue change (TTM)
13.93%
Earnings per share change (TTM)
-89.98%
3-year revenue growth (CAGR)
26.41%
Jaguar Health News
AllArticlesVideos
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Accesswire·2 weeks ago
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca
Accesswire·2 weeks ago
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jaguar Health stock?
Jaguar Health (JAGX) has a market cap of $3.2M as of July 25, 2025.
What is the P/E ratio for Jaguar Health stock?
The price to earnings (P/E) ratio for Jaguar Health (JAGX) stock is 0 as of July 25, 2025.
Does Jaguar Health stock pay dividends?
No, Jaguar Health (JAGX) stock does not pay dividends to its shareholders as of July 25, 2025.
When is the next Jaguar Health dividend payment date?
Jaguar Health (JAGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Jaguar Health?
Jaguar Health (JAGX) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.